Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kevin D Mlynek"'
Autor:
Jeffrey B Kaplan, Kevin D Mlynek, Hashani Hettiarachchi, Yonas A Alamneh, Lionel Biggemann, Daniel V Zurawski, Chad C Black, Charles E Bane, Robert K Kim, Mark S Granick
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205526 (2018)
Staphylococcal extracellular polymeric substances (EPS) such as extracellular DNA (eDNA) and poly-N-acetylglucosamine surface polysaccharide (PNAG) mediate numerous virulence traits including host colonization and antimicrobial resistance. Previous s
Externí odkaz:
https://doaj.org/article/0a6e3a1ad6de45fe852d4bcbf8971cd5
Autor:
Christopher K. Cote, Kevin D. Mlynek, Christopher P. Klimko, Sergei S. Biryukov, Sherry Mou, Melissa Hunter, Nathaniel O. Rill, Jennifer L. Dankmeyer, Jeremey A. Miller, Yuli Talyansky, Michael L. Davies, J. Matthew Meinig, Stephanie A. Halasohoris, Anette M. Gray, Jade L. Spencer, Ashley L. Babyak, M. Kelly Hourihan, Bobby J. Curry, Ronald G. Toothman, Sara I. Ruiz, Xiankun Zeng, Keersten M. Ricks, Tamara L. Clements, Christina E. Douglas, Suma Ravulapalli, Christopher P. Stefan, Charles J. Shoemaker, Mindy G. Elrod, Jay E. Gee, Zachary P. Weiner, Ju Qiu, Joel A. Bozue, Nancy A. Twenhafel, David DeShazer
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 10, Pp 2056-2069 (2024)
In the United States in 2021, an outbreak of 4 cases of Burkholderia pseudomallei, the etiologic agent of melioidosis and a Tier One Select Agent (potential for deliberate misuse and subsequent harm), resulted in 2 deaths. The causative strain, B. ps
Externí odkaz:
https://doaj.org/article/8ea8582aa67e4680aa3494f13afc1315
Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague
Autor:
Michael L. Davies, Sergei S. Biryukov, Nathaniel O. Rill, Christopher P. Klimko, Melissa Hunter, Jennifer L. Dankmeyer, Jeremy A. Miller, Jennifer L. Shoe, Kevin D. Mlynek, Yuli Talyansky, Ronald G. Toothman, Ju Qiu, Joel A. Bozue, Christopher K. Cote
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundYersinia pestis is the etiological agent of plague, which can manifest as bubonic, septicemic, and/or pneumonic disease. Plague is a severe and rapidly progressing illness that can only be successfully treated with antibiotics initiated ear
Externí odkaz:
https://doaj.org/article/32e4ce5d271c4416bfa144b9a94b89b9
Autor:
Kevin D. Mlynek, Curtis R. Cline, Sergei S. Biryukov, Ronald G. Toothman, Beth A. Bachert, Christopher P. Klimko, Jennifer L. Shoe, Melissa Hunter, Zander M. Hedrick, Jennifer L. Dankmeyer, Sherry Mou, David P. Fetterer, Ju Qiu, Eric D. Lee, Christopher K. Cote, Qingmei Jia, Marcus A. Horwitz, Joel A. Bozue
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTFrancisella tularensis is one of the several biothreat agents for which a licensed vaccine is needed. To ensure vaccine protection is achieved across a range of virulent F. tularensis strains, we assembled and characterized a panel of F. tula
Externí odkaz:
https://doaj.org/article/0ace613ea2ce4951941639be362626b4
Autor:
Kevin D. Mlynek, Joel A. Bozue
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
The notoriety of high-consequence human pathogens has increased in recent years and, rightfully, research efforts have focused on understanding host-pathogen interactions. Francisella tularensis has been detected in an impressively broad range of ver
Externí odkaz:
https://doaj.org/article/af6b0e0846dd4bd1ad0ca2f678a4d9a6
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2022)
Biofilms have been established as an important lifestyle for bacteria in nature as these structured communities often enable survivability and persistence in a multitude of environments. Francisella tularensis is a facultative intracellular Gram-nega
Externí odkaz:
https://doaj.org/article/ebb82eec93854509b89903183f4ab23d
Autor:
Beth A. Bachert, Joshua B. Richardson, Kevin D. Mlynek, Christopher P. Klimko, Ronald G. Toothman, David P. Fetterer, Andrea E. Luquette, Kitty Chase, Jessica L. Storrs, Ashley K. Rogers, Christopher K. Cote, David A. Rozak, Joel A. Bozue
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Francisella tularensis is one of several biothreat agents for which a licensed vaccine is needed to protect against this pathogen. To aid in the development of a vaccine protective against pneumonic tularemia, we generated and characterized a panel o
Externí odkaz:
https://doaj.org/article/a80171e1877243d9bea5dbe6a857e695
Autor:
Fabrice V. Biot, Beth A. Bachert, Kevin D. Mlynek, Ronald G. Toothman, Galina I. Koroleva, Sean P. Lovett, Christopher P. Klimko, Gustavo F. Palacios, Christopher K. Cote, Jason T. Ladner, Joel A. Bozue
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Francisella tularensis, the causative agent of tularemia, is capable of causing disease in a multitude of mammals and remains a formidable human pathogen due to a high morbidity, low infectious dose, lack of a FDA approved vaccine, and ease of aeroso
Externí odkaz:
https://doaj.org/article/55fa7e353ff84d79aac93e35aa1ef1a8
Autor:
Kevin D Mlynek, Beth A. Bachert, Ronald G. Toothman, Andrea E Luquette, Kitty Chase, David P Fetterer, Christopher K. Cote, Joel A. Bozue, Jessica L Storrs, Joshua Richardson, Christopher P. Klimko, David A Rozak, Ashley K Rogers
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology, Vol 12 (2021)
Francisella tularensisis one of several biothreat agents for which a licensed vaccine is needed to protect against this pathogen. To aid in the development of a vaccine protective against pneumonic tularemia, we generated and characterized a panel of
Autor:
Kevin D Mlynek, Beth A. Bachert, Sean Lovett, Fabrice Biot, G. I. Koroleva, Christopher P. Klimko, Jason T. Ladner, Joel A. Bozue, Gustavo Palacios, Christopher K. Cote, Ronald G. Toothman
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology, Vol 11 (2020)
Francisella tularensis, the causative agent of tularemia, is capable of causing disease in a multitude of mammals and remains a formidable human pathogen due to a high morbidity, low infectious dose, lack of a FDA approved vaccine, and ease of aeroso